Coming to America: Genomic surveillance and how B.1.1.7 arrived in the US.

Qiu, Xueting; Hanage, William P; Taylor, Bradford P

Qiu, Xueting; Hanage, William P; Taylor, Bradford P.

Qiu X; Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. Electronic address: xuetingqiu@hsph.harvard.edu.
Hanage WP; Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Taylor BP; Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Cell ; 184(10): 2532-2534, 2021 05 13.

Article in English | MEDLINE | ID: covidwho-1229877

ABSTRACT

ABSTRACT

In this issue of Cell, Washington et al. and Alpert et al. demonstrate the value of genomic surveillance when studying the introduction of the B.1.1.7 variant to the US and illustrate the challenge that results from the lack of good sampling strategies.

Subject(s)

COVID-19/epidemiology; Communicable Diseases, Emerging/epidemiology; Epidemiological Monitoring; Metagenomics/methods; SARS-CoV-2/isolation & purification; COVID-19/virology; Communicable Diseases, Emerging/virology; Humans; SARS-CoV-2/genetics; United States/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Communicable Diseases, Emerging / Metagenomics / Epidemiological Monitoring / SARS-CoV-2 / COVID-19 Type of study: Observational study Topics: Variants Limits: Humans Country/Region as subject: North America Language: English Journal: Cell Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google